Eastern Bank’s Edwards Lifesciences EW Stock Holding History

Eastern Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$126K	Sell	1,393 -17	-1%	-$1.42K	﹤0.01%	461
2026 Q1	$113K	Sell	1,410 -91	-6%	-$7.5K	﹤0.01%	450
2025 Q4	$128K	Buy	1,501 +70	+5%	+$5.75K	﹤0.01%	428
2025 Q3	$111K	Buy	1,431 +17	+1%	+$1.33K	﹤0.01%	449
2025 Q2	$111K	Sell	1,414 -97	-6%	-$7.23K	﹤0.01%	439
2025 Q1	$110K	Buy	1,511 +71	+5%	+$5.08K	﹤0.01%	442
2024 Q4	$107K	Sell	1,440 -41	-3%	-$2.87K	﹤0.01%	457
2024 Q3	$97.7K	Buy	+1,481	New	+$108K	﹤0.01%	469

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

Eastern Bank's EW Position: Q2 2026 in Review

Eastern Bank reduced its Edwards Lifesciences (EW) stake by 1.2% in Q2 2026, selling an estimated $1.42K and leaving 1,393 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Eastern Bank first reported a position in EW in Q3 2024 and has held it in 8 quarters since. The position peaked at $128K in Q4 2025. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Eastern Bank held 1,393 shares of Edwards Lifesciences worth $126K as of Q2 2026.
Eastern Bank sold 17 Edwards Lifesciences shares in Q2 2026, an estimated $1.42K.
Edwards Lifesciences made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #461 holding.
Eastern Bank first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
Eastern Bank's Edwards Lifesciences position peaked at $128K in Q4 2025.
195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.